Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition
- PMID: 1176815
Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition
Abstract
The effect of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition, utilizing hydroxylamine, on the formation of clot structure in vitro was studied in human platelet-free plasma systems. Rheological and biochemical techniques were employed to relate changes in clot elasticity and viscosity to clot structure formation following recalcification of citrate anticoagulated samples. Classical theories of linear viscoelasticity for swollen crosslinked materials were shown to give an excellent estimate of the number of covalent crosslinks per fibrin monomer, which is directly attainable from rheological data. SDS gel electrophoresis was utilized to show qualitatively that decreases in maximum clot elasticity, at constant fibrinogen concentration, are directly related to a decrease in Factor XIII-mediated intermolecular crosslinking. The use of the technique to investigate both kinetic and equilibrium crosslinking (or structure formation) abnormalities in plasma systems is discussed.
Similar articles
-
Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.Thromb Haemost. 1992 Sep 7;68(3):315-20. Thromb Haemost. 1992. PMID: 1279832
-
Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.Circulation. 2003 May 13;107(18):2326-30. doi: 10.1161/01.CIR.0000066690.89407.CE. Epub 2003 Apr 21. Circulation. 2003. PMID: 12707238
-
Distribution of alpha-polymers and residual alpha-chains in in vitro and in vivo formed fibrin clots.Behring Inst Mitt. 1986 Feb;(79):24-30. Behring Inst Mitt. 1986. PMID: 3718409
-
Rheology of blood coagulation.Biorheology. 1996 Mar-Apr;33(2):101-17. doi: 10.1016/0006-355X(96)00010-8. Biorheology. 1996. PMID: 8679959 Review.
-
Factor XIII deficiency.Haemophilia. 2008 Nov;14(6):1190-200. doi: 10.1111/j.1365-2516.2008.01857.x. Haemophilia. 2008. PMID: 19141159 Review.
Cited by
-
Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.Front Immunol. 2019 Jul 16;10:1626. doi: 10.3389/fimmu.2019.01626. eCollection 2019. Front Immunol. 2019. PMID: 31379831 Free PMC article.
-
Acetaldehyde exposure alters fibrin polymerization, fibrinolysis, and fibrin network structure in vitro.Res Pract Thromb Haemost. 2025 Jun 6;9(4):102921. doi: 10.1016/j.rpth.2025.102921. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40678355 Free PMC article.
-
Structure of fibrin and fibrinmonomer in renal and hepatic failure.Klin Wochenschr. 1980 May 16;58(10):533-5. doi: 10.1007/BF01477072. Klin Wochenschr. 1980. PMID: 7392532
-
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.Blood. 2015 Oct 15;126(16):1940-8. doi: 10.1182/blood-2015-06-652263. Epub 2015 Aug 31. Blood. 2015. PMID: 26324704 Free PMC article.
-
Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Anesth Analg. 2012 Feb;114(2):275-85. doi: 10.1213/ANE.0b013e31823a088c. Epub 2011 Nov 21. Anesth Analg. 2012. PMID: 22104070 Free PMC article. Review.